Publication:
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis

dc.contributor.authorCarmona, F David
dc.contributor.authorMartín, José-Ezequiel
dc.contributor.authorBeretta, Lorenzo
dc.contributor.authorSimeón, Carmen P
dc.contributor.authorCarreira, Patricia E
dc.contributor.authorCallejas, José Luis
dc.contributor.authorFernández-Castro, Mónica
dc.contributor.authorSáez-Comet, Luis
dc.contributor.authorBeltrán, Emma
dc.contributor.authorCamps, María Teresa
dc.contributor.authorEgurbide, María Victoria
dc.contributor.authorAiró, Paolo
dc.contributor.authorScorza, Raffaella
dc.contributor.authorLunardi, Claudio
dc.contributor.authorHunzelmann, Nicolas
dc.contributor.authorRiemekasten, Gabriela
dc.contributor.authorWitte, Torsten
dc.contributor.authorKreuter, Alexander
dc.contributor.authorDistler, Jörg H W
dc.contributor.authorMadhok, Rajan
dc.contributor.authorShiels, Paul
dc.contributor.authorvan Laar, Jacob M
dc.contributor.authorFonseca, Carmen
dc.contributor.authorDenton, Christopher
dc.contributor.authorHerrick, Ariane
dc.contributor.authorWorthington, Jane
dc.contributor.authorSchuerwegh, Annemie J
dc.contributor.authorVonk, Madelon C
dc.contributor.authorVoskuyl, Alexandre E
dc.contributor.authorRadstake, Timothy R D J
dc.contributor.authorMartín, Javier
dc.contributor.authoraffiliation[Carmona,FD; Martín JE] Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain. [ Beretta,L; Scorza,R] Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, University of Milan, Italy. [ Carmen,P S] Department of Internal Medicine, Hospital Vall d’Hebron, Barcelona, Spain. [Carreira,P E] Department of Rheumatology, Hospital 12 de Octubre, Madrid, Spain. [Callejas,J.L. ] Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, Spain. [Fernández-Castro,M.] Department of Rheumatology, Hospital Puerta de Hierro Majadahonda, Madrid, Spain. [Sáez-Comet,L] Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain. [Beltran,E.] Department of Rheumatology, Hospital General Universitario de Valencia, Spain. [Camps,MT.] Department of Internal Medicine, Hospital Carlos Haya, Málaga, Spain. [Egurbide,M.V.] Department of Internal Medicine, Hospital de Cruces, Barakaldo, Spain. [Airo,P.] Servizio di Reumatologia ed Immunologia Clinica Spedali Civili, Brescia, Italy. [Lunardi,C] Department of Medicine, Universita` degli Studi di Verona, Verona, Italy. [Hunzelmann, N] Department of Dermatology, University of Cologne, Cologne, Germany. [Riemekasten,G] Department of Rheumatology and Clinical Immunology, Charite´ University Hospital, Berlin, Germany. [Witte,T] Hannover Medical School, Hannover, Germany. [Kreuter,A] Ruhr University of Bochum, Germany. [Distler,JHW] Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany. [Madhok,R; Shiels,P] Centre for Rheumatic Diseases, Glasgow Royal Infirmary, University of Glasgow, United Kingdom. [Van Laar,JM] Institute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom. [Fonseca,C; Denton,C] Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom. [Herrick,A; Worthington, J] Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom. [Schuerwegh,AJ] Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. [Vonk,MC; Radstake,T.R.D] Department of Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. [Voskuyl,AE] Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands. [Radstake,T.R.D] Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherland.es
dc.contributor.funder17552, Arthritis Research UK, United Kingdom;
dc.contributor.groupThe Spanish Scleroderma Groupes
dc.date.accessioned2015-08-04T12:37:31Z
dc.date.available2015-08-04T12:37:31Z
dc.date.issued2013-08
dc.descriptionJournal Article; Research Support, Non-U.S. Gov't;es
dc.description.abstractSystemic sclerosis (SSc) is a fibrotic autoimmune disease in which the genetic component plays an important role. One of the strongest SSc association signals outside the human leukocyte antigen (HLA) region corresponds to interferon (IFN) regulatory factor 5 (IRF5), a major regulator of the type I IFN pathway. In this study we aimed to evaluate whether three different haplotypic blocks within this locus, which have been shown to alter the protein function influencing systemic lupus erythematosus (SLE) susceptibility, are involved in SSc susceptibility and clinical phenotypes. For that purpose, we genotyped one representative single-nucleotide polymorphism (SNP) of each block (rs10488631, rs2004640, and rs4728142) in a total of 3,361 SSc patients and 4,012 unaffected controls of Caucasian origin from Spain, Germany, The Netherlands, Italy and United Kingdom. A meta-analysis of the allele frequencies was performed to analyse the overall effect of these IRF5 genetic variants on SSc. Allelic combination and dependency tests were also carried out. The three SNPs showed strong associations with the global disease (rs4728142: P  = 1.34×10(-8), OR  = 1.22, CI 95%  = 1.14-1.30; rs2004640: P  = 4.60×10(-7), OR  = 0.84, CI 95%  = 0.78-0.90; rs10488631: P  = 7.53×10(-20), OR  = 1.63, CI 95%  = 1.47-1.81). However, the association of rs2004640 with SSc was not independent of rs4728142 (conditioned P  = 0.598). The haplotype containing the risk alleles (rs4728142*A-rs2004640*T-rs10488631*C: P  = 9.04×10(-22), OR  = 1.75, CI 95%  = 1.56-1.97) better explained the observed association (likelihood P-value  = 1.48×10(-4)), suggesting an additive effect of the three haplotypic blocks. No statistical significance was observed in the comparisons amongst SSc patients with and without the main clinical characteristics. Our data clearly indicate that the SLE risk haplotype also influences SSc predisposition, and that this association is not sub-phenotype-specific.es
dc.description.versionYeses
dc.identifier.citationCarmona FD, Martín JE, Beretta L, Simeón CP, Carreira PE, Callejas JL, et al. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS ONE. 2013; 8(1):e54419es
dc.identifier.doi10.1371/journal.pone.0054419
dc.identifier.essn1932-6203
dc.identifier.pmcPMC3553151
dc.identifier.pmid23372721
dc.identifier.urihttp://hdl.handle.net/10668/1942
dc.journal.titlePloS one
dc.language.isoen
dc.publisherPublic Library of Sciencees
dc.relation.publisherversionhttp://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054419es
dc.rights.accessRightsopen access
dc.subjectFactores reguladores del interferónes
dc.subjectPredisposición genética a la enfermedades
dc.subjectHaplotiposes
dc.subjectPolimorfismo de nucleótido simplees
dc.subjectLupus eritematoso sistémicoes
dc.subjectDesequilibrio de ligamientoes
dc.subjectGrupo de ascendencia continental europeaes
dc.subjectFactores de riesgoes
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Population Groups::Continental Population Groups::European Continental Ancestry Groupes
dc.subject.meshMedical Subject Headings::Check Tags::Femalees
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Gene Frequencyes
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genetic Locies
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype::Genetic Predisposition to Diseasees
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype::Haplotypeses
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intracellular Signaling Peptides and Proteins::Adaptor Proteins, Signal Transducing::Interferon Regulatory Factorses
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Linkage::Linkage Disequilibriumes
dc.subject.meshMedical Subject Headings::Diseases::Immune System Diseases::Autoimmune Diseases::Lupus Erythematosus, Systemices
dc.subject.meshMedical Subject Headings::Check Tags::Malees
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Phenotypees
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Polymorphism, Genetices
dc.subject.meshMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Factors::Causality::Risk Factorses
dc.subject.meshMedical Subject Headings::Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Scleroderma, Systemices
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Alleleses
dc.titleThe systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosises
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Carmona_TheSystemicLupus.pdf
Size:
158.11 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado